Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension

American Journal of Cardiology

Volumn 109, Issue 10, 2012, Pages 1504-1509

  So, Petsy Pui Sze ^a   Davies, Ross A ^a   Chandy, George ^a   Stewart, Duncan ^a   Beanlands, Rob S B ^a   Haddad, Haissam ^a   Pugliese, Carolyn ^a   Mielniczuk, Lisa M ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; BISOPROLOL; METOPROLOL; NADOLOL; PROPRANOLOL;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DRUG EFFICACY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; ONTARIO; PROSPECTIVE STUDIES; PULMONARY WEDGE PRESSURE; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR RESISTANCE; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT;

EID: 84860475234     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.01.368     Document Type: Article

References (21)

1. V.V. McLaughlin, S.L. Archer, D.B. Badesch, R.J. Barst, H.W. Farber, J.R. Lindner, M.A. Mathier, M.D. McGoon, M.H. Park, R.S. Rosenson, L.J. Rubin, V.F. Tapson, J. Varga American College of Cardiology Foundation, Task Force on Expert Consensus Documents, American Heart Association, American College of Chest Physicians, American Thoracic Society, American Heart Association, American College of Chest Physicians, American Thoracic Society, Pulmonary Hypertension Association ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association J Am Coll Cardiol 53 2009 1573 1619
2. G. Simonneau, I.M. Robbins, M. Beghetti, R.N. Channick, M. Delcroix, C.P. Denton, C.G. Elliott, S.P. Gaine, M.T. Gladwin, Z.C. Jing, M.J. Krowka, D. Langleben, N. Nakanishi, R. Souza Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 2009 S43 S54
3. Guidelines and Protocols Advisory Committee Clinical practice guidelines and protocols in British Columbia Heart failure care: appendix B: beta blockers http://www.bcguidelines.ca/gpac/pdf/heart-failure-appendix-b.pdf Accessed December 13, 2011
4. J.G. Howlett, R.S. McKelvie, J.M. Arnold, J. Costigan, P. Dorian, A. Ducharme, E. Estrella-Holder, J.A. Ezekowitz, N. Giannetti, H. Haddad, G.A. Heckman, A.M. Herd, D. Isaac, P. Jong, S. Kouz, P. Liu, E. Mann, G.W. Moe, R.T. Tsuyuki, H.J. Ross, M. White Canadian Cardiovascular Society Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials Can J Cardiol 25 2009 85 105
5. D.B. Badesch, G.E. Raskob, C.G. Elliott, A.M. Krichman, H.W. Farber, A.E. Frost, R.J. Barst, R.L. Benza, T.G. Liou, M. Turner, S. Giles, K. Feldkircher, D.P. Miller, M.D. McGoon Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry Chest 137 2010 376 387
6. G.E. D'Alonzo, R.J. Barst, S.M. Ayres, E.H. Bergofsky, B.H. Brundage, K.M. Detre, A.P. Fishman, R.M. Goldring, B.M. Groves, J.T. Kernis Survival in patients with primary pulmonary hypertension Results from a national prospective registry Ann Intern Med 115 1991 343 349
7. D.E. Lilienfeld, L.J. Rubin Mortality from primary pulmonary hypertension in the United States, 1979-1996 Chest 117 2000 796 800
8. V.V. McLaughlin, K.W. Presberg, R.L. Doyle, S.H. Abman, D.C. McCrory, T. Fortin, G. Ahearn American College of Chest Physicians Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines Chest 126 2004 78S 92S
9. O. Sitbon, M. Humbert, H. Nunes, F. Parent, G. Garcia, P. Hervé, M. Rainisio, G. Simonneau Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival J Am Coll Cardiol 40 2002 780 788
10. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, T.G. Ganiats, M. Jessup, M.A. Konstam, D.M. Mancini, K. Michl, J.A. Oates, P.S. Rahko, M.A. Silver, L.W. Stevenson, C.W. Yancy American College of Cardiology Foundation, American Heart Association 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 suppl 2009 e1 e90
11. S. Provencher, P. Herve, X. Jais, D. Lebrec, M. Humbert, G. Simonneau, O. Sitbon Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension Gastroenterology 130 2006 120 126
12. S. Velez-Roa, A. Ciarka, B. Najem, J.L. Vachiery, R. Naeije, P. van de Borne Increased sympathetic nerve activity in pulmonary artery hypertension Circulation 110 2004 1308 1312
13. I.R. Henkens, S.A. Van Wolferen, C.T. Gan, A. Boonstra, C.A. Swenne, J.W. Twisk, O. Kamp, E.E. van der Wall, M.J. Schalij, A. Vonk-Noordegraaf, H.W. Vliegen Relation of resting heart rate to prognosis in patients with idiopathic pulmonary arterial hypertension Am J Cardiol 103 2009 1451 1456
14. C.L. McGowan, J.S. Swiston, C.F. Notarius, S. Mak, B.L. Morris, P.E. Picton, J.T. Granton, J.S. Floras Discordance between microneurographic and heart-rate spectral indices of sympathetic activity in pulmonary arterial hypertension Heart 95 2009 754 758
15. A.E. Lammers, E. Munnery, A.A. Hislop, S.G. Haworth Heart rate variability predicts outcome in children with pulmonary arterial hypertension Int J Cardiol 142 2010 159 165
16. F. Pourageaud, V. Leblais, N. Bellance, R. Marthan, B. Muller Role of beta2-adrenoceptors (beta-AR), but not beta1-, beta3-AR and endothelial nitric oxide, in beta-AR-mediated relaxation of rat intrapulmonary artery Naunyn Schmiedebergs Arch Pharmacol 372 2005 14 23
17. V. Leblais, E. Delannoy, F. Fresquet, H. Bégueret, N. Bellance, S. Banquet, C. Allières, L. Leroux, C. Desgranges, A. Gadeau, B. Muller Beta-adrenergic relaxation in pulmonary arteries: preservation of the endothelial nitric oxide-dependent beta2 component in pulmonary hypertension Cardiovasc Res 77 2008 202 210
18. M.L. Handoko, F.S. de Man, C.P. Allaart, W.J. Paulus, N. Westerhof, A. Vonk-Noordegraaf Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart Eur Respir Rev 19 2010 72 82
19. H.J. Bogaard, K. Abe, A. Vonk Noordegraaf, N.F. Voelkel The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension Chest 135 2009 794 804
20. R. Naeije Treatment of right heart failure on pulmonary arterial hypertension: is going left a step in the right direction? Eur Respir Rev 19 2010 4 6
21. H.J. Bogaard, R. Natarajan, S. Mizuno, A. Abbate, P.J. Chang, V.Q. Chau, N.N. Hoke, D. Kraskauskas, M. Kasper, F.N. Salloum, N.F. Voelkel Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats Am J Respir Crit Care Med 182 2010 652 660